Please use this identifier to cite or link to this item: https://doi.org/10.1016/S1097-2765(03)00490-8
Title: Regulation of NF-κB Signaling by Pin1-Dependent Prolyl Isomerization and Ubiquitin-Mediated Proteolysis of p65/RelA
Authors: Ryo, A.
Suizu, F.
Perrem, K.
Liou, Y.-C. 
Wulf, G.
Lu, K.P.
Yoshida, Y.
Rottapel, R.
Yamaoka, S.
Issue Date: 2003
Citation: Ryo, A., Suizu, F., Perrem, K., Liou, Y.-C., Wulf, G., Lu, K.P., Yoshida, Y., Rottapel, R., Yamaoka, S. (2003). Regulation of NF-κB Signaling by Pin1-Dependent Prolyl Isomerization and Ubiquitin-Mediated Proteolysis of p65/RelA. Molecular Cell 12 (6) : 1413-1426. ScholarBank@NUS Repository. https://doi.org/10.1016/S1097-2765(03)00490-8
Abstract: The transcription factor NF-κB is activated by the degradation of its inhibitor IκBα, resulting in its nuclear translocation. However, the mechanism by which nuclear NF-κB is subsequently regulated is not clear. Here we demonstrate that NF-κB function is regulated by Pin1-mediated prolyl isomerization and ubiquitin-mediated proteolysis of its p65/RelA subunit. Upon cytokine treatment, Pin1 binds to the pThr254-Pro motif in p65 and inhibits p65 binding to IκBα, resulting in increased nuclear accumulation and protein stability of p65 and enhanced NF-κB activity. Significantly, Pin1-deficient mice and cells are refractory to NF-κB activation by cytokine signals. Moreover, the stability of p65 is controlled by ubiquitin-mediated proteolysis, facilitated by a cytokine signal inhibitor, SOCS-1, acting as a ubiquitin ligase. These findings uncover two important mechanisms of regulating NF-κB signaling and offer new insight into the pathogenesis and treatment of some human diseases such as cancers.
Source Title: Molecular Cell
URI: http://scholarbank.nus.edu.sg/handle/10635/38232
ISSN: 10972765
DOI: 10.1016/S1097-2765(03)00490-8
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.